According to the sources provided, Wegovy appears to be more affordable than Ozempic. Drugpatentwatch.com [1] shows that the patent for Ozempic (semaglutide) will expire in 2030, while the patent for Wegovy (semaglutide injection) will expire in 2032. This suggests that Ozempic may be more expensive due to its exclusivity, while Wegovy may be more affordable due to its longer patent life.

Additionally, Quick.md [2] compares the prices of both drugs and notes that Wegovy is significantly cheaper than Ozempic. According to their data, a 2-week supply of Wegovy costs around $400, while a 2-week supply of Ozempic costs around $700. This suggests that Wegovy may be a more affordable option for those looking for a weight loss drug.

NBC News [3] also reports that demand for both drugs has soared, but notes that Ozempic is more expensive than Wegovy. The article states that Ozempic can cost up to $1,000 per month, while Wegovy is priced at around $1,300 for a 3-month supply. This further supports the idea that Wegovy may be a more affordable option compared to Ozempic.

In conclusion, based on the sources provided, it appears that Wegovy is more affordable than Ozempic. While both drugs have seen a surge in demand, Wegovy is priced significantly lower than Ozempic and has a longer patent life, which may contribute to its affordability. However, it's important to note that prices may vary depending on factors such as insurance coverage and location. Patients should consult with their healthcare provider and insurance company to determine the most affordable option for their specific needs.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://quick.md/blog/drugs-information-prices/ozempic-versus-wegovy/
[3] https://www.nbcnews.com/health/health-news/ozempic-wegovy-weight-loss-drugs-demand-soars-rcna68425